Douglas Greene

Douglas Greene, PhD FCP, is a highly experienced clinical pharmacologist with a distinguished career in various leadership roles within the biopharmaceutical industry. Currently serving as a Clinical Pharmacologist at Day One Biopharmaceuticals, Douglas has previously held the position of Vice President, Clinical Pharmacology at Ambrx Biopharma, Inc., a subsidiary of Johnson & Johnson. Douglas has also led clinical pharmacology efforts as Executive Director at both Kura Oncology, Inc. and Spectrum Pharmaceuticals, Inc. Additionally, Douglas has served as Global Head of Clinical Pharmacology at Kyowa Hakko Kirin Pharma, Inc., contributing significantly to advancements in the field.